To date, twelve therapies have been approved to treat pulmonary arterial hypertension (PAH). Of these, three were approved last…
Articles by Maureen Newman
A 2011 study entitled, “Pulmonary hypertension in heart failure with preserved ejection fraction: a target of…
While it is commonly accepted that patients with scleroderma are at a higher risk for…
A recent study conducted in Brazil suggests noninvasive positive pressure ventilation (CPAP) does not contribute to ventilation-related complications in…
A protein within the glycolytic metabolism pathway, which is key to providing energy for cell processes, is increased in…
When admitted to the intensive care unit (ICU), chances are high that the patient has an existing condition in…
Patients who show signs of pulmonary hypertension are reliably diagnosed non-invasively at the doctor’s office using Doppler echocardiography, a…
Clinical application of sildenafil, a phosphodiesterase inhibitor studied for efficacy in treating pulmonary hypertension, to…
New insights into the molecular mechanisms of chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary arterial hypertension (iPAH) generally…
While a major population of pulmonary hypertension patients are diagnosed with idiopathic or arterial pulmonary hypertension, a population of…
Overwhelmingly positive results of Mast Therapeutics, Inc.‘s Phase 2 clinical trial of AIR001 (sodium nitrite, or Aironite®) inhalation solution…
When Gilead Sciences, Inc. initiated a clinical trial for first-line combination therapy for pulmonary arterial hypertension treatment, the company…